Delivery Order SPE2DB20D3101-SPE2DB25FRLD8
Award Date
5/23/25
Potential Completion Date
5/27/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.04 firm fixed-price award is for the supply of 4,567,104,095 units of 4 mg naloxone hydrochloride nasal spray, which is a critical medication used to reverse opioid overdoses. The award is not designated under any set-aside program, indicating open competition. This delivery order is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,061.84, is for the delivery of 4,567,475,840 units of Naloxone HCL 4 mg nasal spray, a critical medication used in the treatment of opioid overdoses. The contract is a firm-fixed-price delivery order with a period of performance through March 6, 2025. This award is part of a larger Indefinite...
This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,994.92 firm fixed-price delivery order is for the supply of 4,561,391,717 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to reverse opioid overdose. This contract does not have a set-aside designation, indicating open competition. The award is associated with a larger $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,120,273 units of Naloxone HCl 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a firm-fixed price of $1,799.28 and a completion date of May 5, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a $4,993.14 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,056,293 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of July 3, 2024 and was awarded on July 2, 2022. This delivery order is part of a larger Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of 4,561,027,452 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The award, valued at $2,931.70, has a firm fixed-price structure and an ultimate completion date of May 24, 2023. This contract is not set aside for any specific business type....
This is a $1,262.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides 4,567,065,647 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a completion date of January 29, 2025. This delivery order is placed under an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award, valued at $2,037.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,161,333 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a firm fixed-price pricing type and an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a $7,772.06 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,365,081 units of Naloxone HCl 4 mg nasal spray by May 28, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...